Maria Palasis
2021
In 2021, Maria Palasis earned a total compensation of $1.8M as President and Chief Executive Officer at Lyra Therapeutics, a 59% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $287,374 |
|---|---|
| Option Awards | $906,410 |
| Salary | $552,115 |
| Other | $8,700 |
| Total | $1,754,599 |
Palasis received $906.4K in option awards, accounting for 52% of the total pay in 2021.
Palasis also received $287.4K in non-equity incentive plan, $552.1K in salary and $8.7K in other compensation.
Rankings
In 2021, Maria Palasis' compensation ranked 6,573rd out of 12,415 executives tracked by ExecPay. In other words, Palasis earned more than 47.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,573 out of 12,415 | 47th |
Division Manufacturing | 2,833 out of 5,505 | 49th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 372 out of 801 | 54th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 230 out of 522 | 56th |
Industry Surgical and Medical Instruments and Apparatus | 145 out of 327 | 56th |
Source: SEC filing on April 27, 2022.
Palasis' colleagues
We found three more compensation records of executives who worked with Maria Palasis at Lyra Therapeutics in 2021.